Review addresses longstanding uncertainty around antihistamines for eczema Researchers advise against routine use and call for updated guidance Adding oral antihistamines to existing eczema treatments is unlikely to lead to clinically important reductions in eczema and itch severity, and may not reduce sleep disturbance or flare-ups, finds a review of the ...
Findings align with existing safety data, supporting continued use of aluminium-adjuvanted vaccines in immunisation programmes. Current evidence does not support direct (causal) associations between aluminium adjuvanted vaccines and serious or long term health outcomes, including autism, diabetes and asthma, finds a review of the latest data published by The BMJ today. Small ...
The BMJ research: sodium-glucose cotransporter-2 inhibitors and risk of autoimmune rheumatic diseases In October 2025, The BMJ published the first nationwide population based cohort study to examine the association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and risk of autoimmune rheumatic diseases (ARDs). Drawing on data from more than ...
Copyright © 2026 BMJ Publishing Group Limited. All rights reserved.
Cookie settings | Accessibility | Cookie policy | Modern Slavery Statement | Privacy policy | Website terms and conditions
